Two of Canada’s largest licensed producers of medical marijuana are facing class action lawsuits after recalling product that tests confirm contained banned pesticides myclobutanil and bifenazate.
On March 6, Toronto law firm Roy O’Connor LLP issued a proposed class action against Mettrum Ltd. A second class action by Halifax-based law firm Wagners, has been proposed against New Brunswick-based OrganiGram.
The newly-announced suit alleges that Mettrum used unauthorized pest control products in the production of some of its medical marijuana products between September 2014 and November 2016. The lawsuit also alleges that the company failed to pay refunds to its customers. The lawsuit seeks millions in damages on behalf of individuals who purchased the affected products.
Bruce Linton, the CEO of Canopy Growth Corporation, which acquired Mettrum in January, has stated that the use of unregistered pest control products was “inexcusable.”
But responding to news of the class action Monday, Canopy Growth issued a statement saying the company “was, and continues to be satisfied with Health Canada’s independent decision to classify the Mettrum recall as a…